2
Jul 2026
Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.







